{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["NLRP3 inflammasome", "ozonated oil", "ozonated triglyceride", "ozone therapy", "sepsis"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [{"AbstractText": ["<b>\u76ee\u7684</b>: \u8113\u6bd2\u75c7\u662f\u4e00\u79cd\u5bbf\u4e3b\u5bf9\u611f\u67d3\u7684\u53cd\u5e94\u5931\u8c03\uff0c\u5177\u6709\u75c5\u6b7b\u7387\u9ad8\u7684\u7279\u70b9\uff0c\u76ee\u524d\u7684\u6cbb\u7597\u65b9\u6cd5\u96be\u4ee5\u8fbe\u5230\u6ee1\u610f\u7684\u7597\u6548\u3002\u7814\u7a76\u8868\u660e\u81ed\u6c27\u6cbb\u7597\u56e0\u5176\u5177\u6709\u52a0\u5f3a\u6297\u611f\u67d3\u548c\u514d\u75ab\u8c03\u8282\u7684\u4f5c\u7528\uff0c\u5728\u591a\u79cd\u611f\u67d3\u53ca\u708e\u75c7\u76f8\u5173\u75be\u75c5\u4e2d\u8d77\u6cbb\u7597\u4f5c\u7528\u3002\u81ed\u6c27\u6cb9\u662f\u91cd\u8981\u7684\u81ed\u6c27\u6cbb\u7597\u65b9\u5f0f\uff0c\u5176\u4e2d\u5173\u952e\u6210\u5206\u4e3a\u9178\u5316\u8102\u80aa\u9178\u916f\u3002\u800c\u9178\u5316\u8102\u80aa\u9178\u916f\u5728\u8113\u6bd2\u75c7\u4e2d\u7684\u4f5c\u7528\u5e76\u4e0d\u660e\u786e\u3002\u672c\u7814\u7a76\u65e8\u5728\u63a2\u7d22\u9178\u5316\u8102\u80aa\u9178\u916f\u5728\u8113\u6bd2\u75c7\u5c0f\u9f20\u6a21\u578b\u4e2d\u7684\u4f5c\u7528\u53ca\u5176\u5206\u5b50\u673a\u5236\u3002<b>\u65b9\u6cd5</b>: \u5229\u7528\u8102\u591a\u7cd6(lipopolysaccharide\uff0cLPS)\u8179\u8154\u6ce8\u5c04\u53ca\u76f2\u80a0\u7ed3\u624e\u7a7f\u5b54\u672f(cecal ligation and puncture\uff0cCLP)\u6784\u5efa\u5c0f\u9f20\u8113\u6bd2\u75c7\u6a21\u578b\uff0c\u53d6\u5c0f\u9f20\u8840\u6e05\u68c0\u6d4b\u708e\u75c7\u56e0\u5b50\uff0c\u91c7\u96c6\u80ba\u7ec4\u7ec7\u8fdb\u884c\u82cf\u6728\u7cbe\u548c\u4f0a\u7ea2(hematoxylin and eosin\uff0cHE)\u67d3\u8272\uff0c\u8bc4\u4f30\u4e0d\u540c\u65f6\u95f4\u70b9\u53ca\u4e0d\u540c\u5242\u91cf\u9178\u5316\u8102\u80aa\u9178\u916f\u5bf9\u8113\u6bd2\u75c7\u708e\u75c7\u56e0\u5b50\u91ca\u653e\u53ca\u76f8\u5173\u80ba\u635f\u4f24\u7684\u5f71\u54cd\u3002\u5728\u6784\u5efa\u8113\u6bd2\u75c7\u6a21\u578b\u540e\u89c2\u5bdf96 h\uff0c\u5206\u6790\u5c0f\u9f20\u5b58\u6d3b\u7387\u3002\u6b64\u5916\uff0c\u7528\u9178\u5316\u8102\u80aa\u9178\u916f\u5904\u7406\u539f\u4ee3\u8179\u8154\u5de8\u566c\u7ec6\u80de\u3001\u4eba\u6025\u6027\u5355\u6838\u7ec6\u80de\u767d\u8840\u75c5\u7ec6\u80de\u7cfbTHP-1\uff0c\u91c7\u7528\u9176\u8054\u514d\u75ab\u5438\u9644\u8bd5\u9a8c(enzyme-linked immunosorbent assay\uff0cELISA)\u6d4b\u5b9a\u708e\u75c7\u56e0\u5b50\u6c34\u5e73\uff0c\u86cb\u767d\u8d28\u5370\u8ff9\u6cd5\u68c0\u6d4b\u534a\u80f1\u6c28\u9178\u86cb\u767d\u9176-1(caspase-1)\u548c\u4e0b\u6e38\u6d88\u76ae\u7d20D(gasdermin-D\uff0cGSDMD)\u86cb\u767d\u7684\u88c2\u89e3\u3002<b>\u7ed3\u679c</b>: \u4e0d\u540c\u65f6\u95f4\u548c\u5242\u91cf\u7684\u9178\u5316\u8102\u80aa\u9178\u916f\u5904\u7406\u5747\u53ef\u51cf\u5c11\u8113\u6bd2\u75c7\u5c0f\u9f20\u708e\u75c7\u5c0f\u4f53\u76f8\u5173\u7ec6\u80de\u56e0\u5b50\u767d\u7ec6\u80de\u4ecb\u7d20(interleukin\uff0cIL)-1\u03b2\u548cIL-18\u7684\u91ca\u653e(\u5747<i>P</i><0.05)\uff0c\u4f46\u5bf9\u7ec6\u80de\u56e0\u5b50IL-6\u548c\u80bf\u7624\u574f\u6b7b\u56e0\u5b50-\u03b1(tumor necrosis factor-\u03b1\uff0cTNF-\u03b1)\u7684\u91ca\u653e\u65e0\u663e\u8457\u5f71\u54cd(\u5747<i>P</i>>0.05)\u3002\u9178\u5316\u8102\u80aa\u9178\u916f\u53ef\u663e\u8457\u63d0\u9ad8\u8113\u6bd2\u75c7\u5c0f\u9f20\u5b58\u6d3b\u7387\uff0c\u51cf\u8f7b\u8113\u6bd2\u75c7\u5c0f\u9f20\u80ba\u635f\u4f24(\u5747<i>P</i><0.05)\u3002\u9178\u5316\u8102\u80aa\u9178\u916f\u53ef\u6291\u5236\u7ecf\u5178\u53ca\u975e\u7ecf\u5178\u9014\u5f84\u8bf1\u5bfc\u7684NOD\u6837\u53d7\u4f53\u70ed\u86cb\u767d\u7ed3\u6784\u57df\u76f8\u5173\u86cb\u767d3(NOD-like receptor family pyrin domain containing 3\uff0cNLRP3)\u708e\u75c7\u5c0f\u4f53\u6d3b\u5316(\u5747<i>P</i><0.05)\uff0c\u4f46\u4e0d\u5f71\u54cd\u9ed1\u8272\u7d20\u7624\u7f3a\u4e4f\u56e0\u5b502 (absent in melanoma 2\uff0cAIM2)\u548c\u542bNLR\u5bb6\u65cfCARD\u7ed3\u6784\u57df4(NLR family CARD domain-containing protein 4\uff0cNLRC4)\u708e\u75c7\u5c0f\u4f53\u7684\u6d3b\u5316(\u5747<i>P></i>0.05)\u3002\u9178\u5316\u8102\u80aa\u9178\u916f\u53ef\u6291\u5236caspase-1\u548c\u4e0b\u6e38GSDMD\u7684\u88c2\u89e3\u3002<b>\u7ed3\u8bba</b>: \u9178\u5316\u8102\u80aa\u9178\u916f\u901a\u8fc7\u51cf\u5c11\u708e\u75c7\u56e0\u5b50\u91ca\u653e\u53ca\u8113\u6bd2\u75c7\u76f8\u5173\u5668\u5b98\u635f\u4f24\u8fdb\u800c\u5728\u8113\u6bd2\u75c7\u4e2d\u8d77\u5230\u4fdd\u62a4\u4f5c\u7528\uff0c\u5176\u673a\u5236\u4e3a\u9178\u5316\u8102\u80aa\u9178\u916f\u6291\u5236NLRP3\u708e\u75c7\u5c0f\u4f53\u7684\u6d3b\u5316\uff0c\u63d0\u793a\u9178\u5316\u8102\u80aa\u9178\u916f\u53ef\u4f5c\u4e3a\u4e00\u79cd\u6cbb\u7597\u8113\u6bd2\u75c7\u6f5c\u5728\u7684\u5019\u9009\u836f\u7269\u3002."]}, {"AbstractText": ["\u8113\u6bd2\u75c7\u662f\u4e00\u79cd\u5bbf\u4e3b\u5bf9\u611f\u67d3\u7684\u53cd\u5e94\u5931\u8c03\uff0c\u5177\u6709\u75c5\u6b7b\u7387\u9ad8\u7684\u7279\u70b9\uff0c\u76ee\u524d\u7684\u6cbb\u7597\u65b9\u6cd5\u96be\u4ee5\u8fbe\u5230\u6ee1\u610f\u7684\u7597\u6548\u3002\u7814\u7a76\u8868\u660e\u81ed\u6c27\u6cbb\u7597\u56e0\u5176\u5177\u6709\u52a0\u5f3a\u6297\u611f\u67d3\u548c\u514d\u75ab\u8c03\u8282\u7684\u4f5c\u7528\uff0c\u5728\u591a\u79cd\u611f\u67d3\u53ca\u708e\u75c7\u76f8\u5173\u75be\u75c5\u4e2d\u8d77\u6cbb\u7597\u4f5c\u7528\u3002\u81ed\u6c27\u6cb9\u662f\u91cd\u8981\u7684\u81ed\u6c27\u6cbb\u7597\u65b9\u5f0f\uff0c\u5176\u4e2d\u5173\u952e\u6210\u5206\u4e3a\u9178\u5316\u8102\u80aa\u9178\u916f\u3002\u800c\u9178\u5316\u8102\u80aa\u9178\u916f\u5728\u8113\u6bd2\u75c7\u4e2d\u7684\u4f5c\u7528\u5e76\u4e0d\u660e\u786e\u3002\u672c\u7814\u7a76\u65e8\u5728\u63a2\u7d22\u9178\u5316\u8102\u80aa\u9178\u916f\u5728\u8113\u6bd2\u75c7\u5c0f\u9f20\u6a21\u578b\u4e2d\u7684\u4f5c\u7528\u53ca\u5176\u5206\u5b50\u673a\u5236\u3002", "\u5229\u7528\u8102\u591a\u7cd6(lipopolysaccharide\uff0cLPS)\u8179\u8154\u6ce8\u5c04\u53ca\u76f2\u80a0\u7ed3\u624e\u7a7f\u5b54\u672f(cecal ligation and puncture\uff0cCLP)\u6784\u5efa\u5c0f\u9f20\u8113\u6bd2\u75c7\u6a21\u578b\uff0c\u53d6\u5c0f\u9f20\u8840\u6e05\u68c0\u6d4b\u708e\u75c7\u56e0\u5b50\uff0c\u91c7\u96c6\u80ba\u7ec4\u7ec7\u8fdb\u884c\u82cf\u6728\u7cbe\u548c\u4f0a\u7ea2(hematoxylin and eosin\uff0cHE)\u67d3\u8272\uff0c\u8bc4\u4f30\u4e0d\u540c\u65f6\u95f4\u70b9\u53ca\u4e0d\u540c\u5242\u91cf\u9178\u5316\u8102\u80aa\u9178\u916f\u5bf9\u8113\u6bd2\u75c7\u708e\u75c7\u56e0\u5b50\u91ca\u653e\u53ca\u76f8\u5173\u80ba\u635f\u4f24\u7684\u5f71\u54cd\u3002\u5728\u6784\u5efa\u8113\u6bd2\u75c7\u6a21\u578b\u540e\u89c2\u5bdf96 h\uff0c\u5206\u6790\u5c0f\u9f20\u5b58\u6d3b\u7387\u3002\u6b64\u5916\uff0c\u7528\u9178\u5316\u8102\u80aa\u9178\u916f\u5904\u7406\u539f\u4ee3\u8179\u8154\u5de8\u566c\u7ec6\u80de\u3001\u4eba\u6025\u6027\u5355\u6838\u7ec6\u80de\u767d\u8840\u75c5\u7ec6\u80de\u7cfbTHP-1\uff0c\u91c7\u7528\u9176\u8054\u514d\u75ab\u5438\u9644\u8bd5\u9a8c(enzyme-linked immunosorbent assay\uff0cELISA)\u6d4b\u5b9a\u708e\u75c7\u56e0\u5b50\u6c34\u5e73\uff0c\u86cb\u767d\u8d28\u5370\u8ff9\u6cd5\u68c0\u6d4b\u534a\u80f1\u6c28\u9178\u86cb\u767d\u9176-1(caspase-1)\u548c\u4e0b\u6e38\u6d88\u76ae\u7d20D(gasdermin-D\uff0cGSDMD)\u86cb\u767d\u7684\u88c2\u89e3\u3002", "\u4e0d\u540c\u65f6\u95f4\u548c\u5242\u91cf\u7684\u9178\u5316\u8102\u80aa\u9178\u916f\u5904\u7406\u5747\u53ef\u51cf\u5c11\u8113\u6bd2\u75c7\u5c0f\u9f20\u708e\u75c7\u5c0f\u4f53\u76f8\u5173\u7ec6\u80de\u56e0\u5b50\u767d\u7ec6\u80de\u4ecb\u7d20(interleukin\uff0cIL)-1\u03b2\u548cIL-18\u7684\u91ca\u653e(\u5747<i>P</i><0.05)\uff0c\u4f46\u5bf9\u7ec6\u80de\u56e0\u5b50IL-6\u548c\u80bf\u7624\u574f\u6b7b\u56e0\u5b50-\u03b1(tumor necrosis factor-\u03b1\uff0cTNF-\u03b1)\u7684\u91ca\u653e\u65e0\u663e\u8457\u5f71\u54cd(\u5747<i>P</i>>0.05)\u3002\u9178\u5316\u8102\u80aa\u9178\u916f\u53ef\u663e\u8457\u63d0\u9ad8\u8113\u6bd2\u75c7\u5c0f\u9f20\u5b58\u6d3b\u7387\uff0c\u51cf\u8f7b\u8113\u6bd2\u75c7\u5c0f\u9f20\u80ba\u635f\u4f24(\u5747<i>P</i><0.05)\u3002\u9178\u5316\u8102\u80aa\u9178\u916f\u53ef\u6291\u5236\u7ecf\u5178\u53ca\u975e\u7ecf\u5178\u9014\u5f84\u8bf1\u5bfc\u7684NOD\u6837\u53d7\u4f53\u70ed\u86cb\u767d\u7ed3\u6784\u57df\u76f8\u5173\u86cb\u767d3(NOD-like receptor family pyrin domain containing 3\uff0cNLRP3)\u708e\u75c7\u5c0f\u4f53\u6d3b\u5316(\u5747<i>P</i><0.05)\uff0c\u4f46\u4e0d\u5f71\u54cd\u9ed1\u8272\u7d20\u7624\u7f3a\u4e4f\u56e0\u5b502 (absent in melanoma 2\uff0cAIM2)\u548c\u542bNLR\u5bb6\u65cfCARD\u7ed3\u6784\u57df4(NLR family CARD domain-containing protein 4\uff0cNLRC4)\u708e\u75c7\u5c0f\u4f53\u7684\u6d3b\u5316(\u5747<i>P></i>0.05)\u3002\u9178\u5316\u8102\u80aa\u9178\u916f\u53ef\u6291\u5236caspase-1\u548c\u4e0b\u6e38GSDMD\u7684\u88c2\u89e3\u3002", "\u9178\u5316\u8102\u80aa\u9178\u916f\u901a\u8fc7\u51cf\u5c11\u708e\u75c7\u56e0\u5b50\u91ca\u653e\u53ca\u8113\u6bd2\u75c7\u76f8\u5173\u5668\u5b98\u635f\u4f24\u8fdb\u800c\u5728\u8113\u6bd2\u75c7\u4e2d\u8d77\u5230\u4fdd\u62a4\u4f5c\u7528\uff0c\u5176\u673a\u5236\u4e3a\u9178\u5316\u8102\u80aa\u9178\u916f\u6291\u5236NLRP3\u708e\u75c7\u5c0f\u4f53\u7684\u6d3b\u5316\uff0c\u63d0\u793a\u9178\u5316\u8102\u80aa\u9178\u916f\u53ef\u4f5c\u4e3a\u4e00\u79cd\u6cbb\u7597\u8113\u6bd2\u75c7\u6f5c\u5728\u7684\u5019\u9009\u836f\u7269\u3002"]}], "GeneralNote": [], "PMID": "37587065", "DateCompleted": {"Year": "2023", "Month": "08", "Day": "18"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "21"}, "Article": {"Language": ["eng", "chi"], "ArticleDate": [], "ELocationID": ["10.11817/j.issn.1672-7347.2023.220634", "1672-7347(2023)06-0809-12"], "Journal": {"ISSN": "1672-7347", "JournalIssue": {"Volume": "48", "Issue": "6", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "28"}}, "Title": "Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences", "ISOAbbreviation": "Zhong Nan Da Xue Xue Bao Yi Xue Ban"}, "ArticleTitle": "Ozonated triglyceride protects against septic lethality via preventing the activation of NLRP3 inflammasome.", "Pagination": {"StartPage": "809", "EndPage": "820", "MedlinePgn": "809-820"}, "Abstract": {"AbstractText": ["Sepsis is a critical dysregulated host response with high mortality and current treatment is difficult to achieve optimal efficacy. Ozone therapy has been revealed to protect infection and inflammation-related diseases due to its role in antibiotic and immunoregulatory effect. Ozonated triglyceride is a key component of ozonated oil that is one of ozone therapy dosage form. However, the potential role of ozonated triglyceride in sepsis remains unclear. This study aims to explore the effect of ozonated triglyceride on septic mouse model and the molecular mechanism.", "Intraperitoneal injection of lipopolysaccharide (LPS), cecal ligation and puncture (CLP) were applied to construct septic mouse model. The mouse serum was obtained for detection of cytokines, and lung tissues were collected for hematoxylin and eosin (HE) staining to evaluate the extent of lung injury in septic mouse with ozonated triglyceride treatment at different time and doses. The survival of septic mice was observed for 96 h and Kaplan-Meier analysis was used to analyze the survival rates. In addition, primary peritoneal macrophages and human acute monocytic-leukemia cell line (THP-1) were treated with inflammasome activators with or without ozonated triglyceride. The level of cytokines was detected by enzyme-linked immunosorbent assay (ELISA). The cleavage of caspase-1 and gasdermin-D (GSDMD) was detected by Western blotting.", "Ozonated triglyceride at different time and doses reduced the release of inflammasome-related cytokines [interleukin (IL)-1\u03b2 and IL-18] (all <i>P</i><0.05) but not pro-inflammatory cytokines such as IL-6 and tumor necrosis factor-\u03b1 (TNF-\u03b1) in septic mice (all <i>P</i>>0.05). Ozonated triglyceride significantly improved the survival rate of septic mice and reduced sepsis-induced lung injury (all <i>P</i><0.05). Ozonated triglyceride significantly suppressed the canonical and non-canonical activation of NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome (all <i>P</i><0.05) but not affected absent in melanoma 2 (AIM2) and NLR family CARD domain-containing protein 4 (NLRC4) inflammasomes in vitro (all <i>P</i>>0.05). Ozonated triglyceride reduced the cleavage of caspase-1 and the downstream GSDMD.", "Ozonated triglyceride presents a protect effect on sepsis lethality via reducing cytokines release and sepsis-related organ injury. The mechanism is that ozonated triglyceride specifically suppresses the activation of NLRP3 inflammasome. Ozonated triglyceride is a promising candidate for sepsis treatment."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha 410013. Drdanwang@163.com."}, {"Identifier": [], "Affiliation": "Medical Ozone Research Center, Central South University, Changsha 410013, China. Drdanwang@163.com."}], "LastName": "Wang", "ForeName": "Dan", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha 410013."}, {"Identifier": [], "Affiliation": "Medical Ozone Research Center, Central South University, Changsha 410013, China."}], "LastName": "Liu", "ForeName": "Yuanhong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha 410013."}, {"Identifier": [], "Affiliation": "Medical Ozone Research Center, Central South University, Changsha 410013, China."}], "LastName": "Zong", "ForeName": "Xiule", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha 410013. sunshine0719happy@163.com."}, {"Identifier": [], "Affiliation": "Medical Ozone Research Center, Central South University, Changsha 410013, China. sunshine0719happy@163.com."}], "LastName": "Yan", "ForeName": "Siyu", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha 410013. xiaoyun3@csu.edu.cn."}, {"Identifier": [], "Affiliation": "Medical Ozone Research Center, Central South University, Changsha 410013, China. xiaoyun3@csu.edu.cn."}], "LastName": "Lu", "ForeName": "Jianyun", "Initials": "J"}], "GrantList": [{"GrantID": "82202391", "Agency": "the National Natural Science Foundation", "Country": ""}, {"GrantID": "2022JJ20093", "Agency": "Outstanding Youth Project of Natural Science Foundation of Hunan Province", "Country": ""}, {"GrantID": "YX202201", "Agency": "the Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University", "Country": ""}], "PublicationTypeList": ["Journal Article"], "VernacularTitle": "\u9178\u5316\u8102\u80aa\u9178\u916f\u901a\u8fc7\u6291\u5236NLRP3\u708e\u75c7\u5c0f\u4f53\u6d3b\u5316\u51cf\u5c11\u8113\u6bd2\u75c7\u81f4\u6b7b\uff08\u82f1\u6587\uff09."}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhong Nan Da Xue Xue Bao Yi Xue Ban", "NlmUniqueID": "101230586", "ISSNLinking": "1672-7347"}, "ChemicalList": [{"RegistryNumber": "EC 3.4.22.36", "NameOfSubstance": "Caspase 1"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammasomes"}, {"RegistryNumber": "0", "NameOfSubstance": "NLR Family, Pyrin Domain-Containing 3 Protein"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Caspase 1"}, {"QualifierName": [], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Inflammasomes"}, {"QualifierName": [], "DescriptorName": "Lung Injury"}, {"QualifierName": [], "DescriptorName": "NLR Family, Pyrin Domain-Containing 3 Protein"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Sepsis"}], "CoiStatement": "The authors declare that they have no conflicts of interest to disclose."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Singer M, Deutschman CS, Seymour CW, et al. . The third international consensus definitions for Sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. 10.1001/jama.2016.0287.", "ArticleIdList": ["10.1001/jama.2016.0287", "PMC4968574", "26903338"]}, {"Citation": "Liu D, Huang SY, Sun JH, et al. . Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options[J]. Mil Med Res, 2022, 9(1): 56. 10.1186/s40779-022-00422-y.", "ArticleIdList": ["10.1186/s40779-022-00422-y", "PMC9547753", "36209190"]}, {"Citation": "Rudd KE, Johnson SC, Agesa KM, et al. . Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395(10219): 200-211. 10.1016/S0140-6736(19)32989-7.", "ArticleIdList": ["10.1016/S0140-6736(19)32989-7", "PMC6970225", "31954465"]}, {"Citation": "\nHealthcare Cost and Utilization Project (HCUP) Statistical Briefs[M/OL]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006[2022-11-14]. https://www. ncbi. nlm. nih. gov/books/NBK52651. ", "ArticleIdList": ["21413206"]}, {"Citation": "Song MS, Zeng QH, Xiang YP, et al. . The antibacterial effect of topical ozone on the treatment of MRSA skin infection[J]. Mol Med Rep, 2018, 17(2): 2449-2455. 10.3892/mmr.2017.8148.", "ArticleIdList": ["10.3892/mmr.2017.8148", "PMC5783482", "29207120"]}, {"Citation": "\u5411\u4e9a\u5e73, \u9c81\u5efa\u4e91, \u674e\u98de\u51e4, \u7b49. \u81ed\u6c27\u5316\u5c71\u8336\u6cb9\u5bf9\u91d1\u9ec4\u8272\u8461\u8404\u7403\u83cc\u7684\u4f53\u5916\u6740\u4f24\u6548\u679c[J]. \u4e2d\u5357\u5927\u5b66\u5b66\u62a5(\u533b\u5b66\u7248), 2018, 43(2): 139-142. 10.11817/j.issn.1672-7347.2018.02.005.", "ArticleIdList": ["10.11817/j.issn.1672-7347.2018.02.005", "29559595"]}, {"Citation": "XIANG Yaping, LU Jianyun, LI Feifeng, et al. . Bactericidal effect of ozonated camellia oil on Staphylococcus aureus in vitro[J]. Journal of Central South University. Medical Science, 2018, 43(2): 139-142. 10.11817/j.issn.1672-7347.2018.02.005.", "ArticleIdList": ["10.11817/j.issn.1672-7347.2018.02.005", "29559595"]}, {"Citation": "\u8c2d\u4e3d\u5a1c, \u9ec4\u5065, \u5362\u9759, \u7b49. \u81ed\u6c27\u6cb9\u5916\u7528\u6cbb\u7597\u5bfb\u5e38\u578b\u94f6\u5c51\u75c5\u7684\u4e34\u5e8a\u7597\u6548[J]. \u4e2d\u5357\u5927\u5b66\u5b66\u62a5(\u533b\u5b66\u7248), 2018, 43(2): 173-178. 10.11817/j.issn.1672-7347.2018.02.012.", "ArticleIdList": ["10.11817/j.issn.1672-7347.2018.02.012", "29559602"]}, {"Citation": "TAN Lina, HUANG Jian, LU Jing, et al. . Clinical efficacy of ozonated oil in the treatment of psoriasis vulgaris[J]. Journal of Central South University. Medical Science, 2018, 43(2): 173-178. 10.11817/j.issn.1672-7347.2018.02.012.", "ArticleIdList": ["10.11817/j.issn.1672-7347.2018.02.012", "29559602"]}, {"Citation": "Zeng JR, Dou JH, Gao LH, et al. . Topical ozone therapy restores microbiome diversity in atopic dermatitis[J]. Int Immunopharmacol, 2020, 80: 106191. 10.1016/j.intimp.2020.106191.", "ArticleIdList": ["10.1016/j.intimp.2020.106191", "31986325"]}, {"Citation": "\u9c81\u5efa\u4e91, \u4ed8\u5fd7\u5175, \u5218\u80dc\u5170, \u7b49. \u533b\u7528\u81ed\u6c27\u6cb9\u76ae\u80a4\u5b89\u5168\u6027\u8bc4\u4ef7[J]. \u4e2d\u5357\u5927\u5b66\u5b66\u62a5(\u533b\u5b66\u7248), 2018, 43(2): 131-138. 10.11817/j.issn.1672-7347.2018.02.004.", "ArticleIdList": ["10.11817/j.issn.1672-7347.2018.02.004", "29559594"]}, {"Citation": "LU Jianyun, FU Zhibing, LIU Shenglan, et al. . Safety evaluation for medical ozone oil on skin[J]. Journal of Central South University. Medical Science, 2018, 43(2): 131-138. 10.11817/j.issn.1672-7347.2018.02.004.", "ArticleIdList": ["10.11817/j.issn.1672-7347.2018.02.004", "29559594"]}, {"Citation": "Zeng JR, Lu JY. Mechanisms of action involved in ozone-therapy in skin diseases[J]. Int Immunopharmacol, 2018, 56: 235-241. 10.1016/j.intimp.2018.01.040.", "ArticleIdList": ["10.1016/j.intimp.2018.01.040", "29414657"]}, {"Citation": "Zeng JR, Du HJ, Zhang YZ, et al. . Efficacy of topical acidified aliphatic ester for treatment of axillary osmidrosis by rebalancing skin microecology[J]. Dermatol Ther, 2021, 34(2): e14844. 10.1111/dth.14844.", "ArticleIdList": ["10.1111/dth.14844", "33528092"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G, Schwartz A, Donna VD. Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19[J]. Antioxidants (Basel), 2020, 9(5): 389. 10.3390/antiox9050389.", "ArticleIdList": ["10.3390/antiox9050389", "PMC7278582", "32384798"]}, {"Citation": "Cattel F, Giordano S, Bertiond C, et al. . Ozone therapy in COVID-19: a narrative review[J]. Virus Res, 2021, 291: 198207. 10.1016/j.virusres.2020.198207.", "ArticleIdList": ["10.1016/j.virusres.2020.198207", "PMC7585733", "33115670"]}, {"Citation": "Izadi M, Cegolon L, Javanbakht M, et al. . Ozone therapy for the treatment of COVID-19 pneumonia: a scoping review[J]. Int Immunopharmacol, 2021, 92: 107307. 10.1016/j.intimp.2020.107307.", "ArticleIdList": ["10.1016/j.intimp.2020.107307", "PMC7752030", "33476982"]}, {"Citation": "Shah M, Captain J, Vaidya V, et al. . Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: a phase 1/11 randomized control trial (SEOT study)[J]. Int Immunopharmacol, 2021, 91: 107301. 10.1016/j.intimp.2020.107301.", "ArticleIdList": ["10.1016/j.intimp.2020.107301", "PMC7758022", "33421928"]}, {"Citation": "Yamanel L, Kaldirim U, Oztas Y, et al. . Ozone therapy and hyperbaric oxygen treatment in lung injury in septic rats[J]. Int J Med Sci, 2011, 8(1): 48-55. 10.7150/ijms.8.48.", "ArticleIdList": ["10.7150/ijms.8.48", "PMC3020392", "21234269"]}, {"Citation": "Kapiciba\u015fi HO, Kiraz HA, Demir ET, et al. . Pulmonary effects of ozone therapy at different doses combined with antibioticotherapy in experimental sepsis model[J/OL]. Acta Cir Bras, 2020, 35(6): e202000604[2022-11-14]. 10.1590/s0102-865020200060000004.", "ArticleIdList": ["10.1590/s0102-865020200060000004", "PMC7357834", "32667585"]}, {"Citation": "Rodr\u00edguez ZZ, Guanche D, Alvarez RG, et al. . Effects of ozone oxidative preconditioning on different hepatic biomarkers of oxidative stress in endotoxic shock in mice[J]. Toxicol Mech Methods, 2011, 21(3): 236-240. 10.3109/15376516.2010.546816.", "ArticleIdList": ["10.3109/15376516.2010.546816", "21329468"]}, {"Citation": "Souza YM, Fontes B, Martins JO, et al. . Evaluation of the effects of ozone therapy in the treatment of intra-abdominal infection in rats[J]. Clinics (Sao Paulo), 2010, 65(2): 195-202. 10.1590/S1807-59322010000200012.", "ArticleIdList": ["10.1590/S1807-59322010000200012", "PMC2827707", "20186304"]}, {"Citation": "Esquerdo KF, Sharma NK, Brunialti MKC, et al. . Inflammasome gene profile is modulated in septic patients, with a greater magnitude in non-survivors[J]. Clin Exp Immunol, 2017, 189(2): 232-240. 10.1111/cei.12971.", "ArticleIdList": ["10.1111/cei.12971", "PMC5508322", "28369745"]}, {"Citation": "Kim MJ, Bae SH, Ryu JC, et al. . SESN2/sestrin2 suppresses sepsis by inducing mitophagy and inhibiting NLRP3 activation in macrophages[J]. Autophagy, 2016, 12(8): 1272-1291. 10.1080/15548627.2016.1183081.", "ArticleIdList": ["10.1080/15548627.2016.1183081", "PMC4968237", "27337507"]}, {"Citation": "Liu Y, Jing YY, Zeng CY, et al. . Scutellarin suppresses NLRP3 inflammasome activation in macrophages and protects mice against bacterial Sepsis [J]. Front Pharmacol, 2017, 8: 975. 10.3389/fphar.2017.00975.", "ArticleIdList": ["10.3389/fphar.2017.00975", "PMC5767189", "29375379"]}, {"Citation": "Wang D, Zhang YN, Xu XM, et al. . YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3[J]. Nat Commun, 2021, 12(1): 2674. 10.1038/s41467-021-22987-3.", "ArticleIdList": ["10.1038/s41467-021-22987-3", "PMC8113592", "33976226"]}, {"Citation": "Wu DY, Li XZ, Wang XS, et al. . Cell-free fat extract protects septic lethality via restraining NLRP3 inflammasome activation[J]. Am J Transl Res, 2022, 14(7): 5201-5214.", "ArticleIdList": ["PMC9360875", "35958494"]}, {"Citation": "Moretti J, Jia BS, Hutchins Z, et al. . Caspase-11 interaction with NLRP3 potentiates the noncanonical activation of the NLRP3 inflammasome[J]. Nat Immunol, 2022, 23(5): 705-717. 10.1038/s41590-022-01192-4.", "ArticleIdList": ["10.1038/s41590-022-01192-4", "PMC9106893", "35487985"]}, {"Citation": "Kayagaki N, Stowe IB, Lee BL, et al. . Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling[J]. Nature, 2015, 526(7575): 666-671. 10.1038/nature15541.", "ArticleIdList": ["10.1038/nature15541", "26375259"]}, {"Citation": "Shi JJ, Zhao Y, Wang K, et al. . Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J]. Nature, 2015, 526(7575): 660-665. 10.1038/nature15514.", "ArticleIdList": ["10.1038/nature15514", "26375003"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "8", "Day": "18", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "8", "Day": "17", "Hour": "0", "Minute": "42"}, {"Year": "2023", "Month": "8", "Day": "16", "Hour": "22", "Minute": "33"}, {"Year": "2023", "Month": "6", "Day": "28"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37587065", "PMC10930436", "10.11817/j.issn.1672-7347.2023.220634", "1672-7347(2023)06-0809-12"]}}], "PubmedBookArticle": []}